A new JAMA study finds that after Dobbs, states with abortion bans saw less use of medication management for first-trimester miscarriages and more reliance on less effective drug regimens and expectant management.
When a pregnancy ends unexpectedly, many people don’t have the luxury of delay. They face decisions about how quickly to address symptoms like bleeding, cramping, and pain—and what options clinicians can safely offer.
A new study published May 18 in the Journal of the American Medical Association links the post–Dobbs rollout of abortion restrictions to changes in miscarriage care in states where abortion is banned at six weeks or earlier.. Researchers found that compared with states without abortion bans. states with bans were associated with a reduction in medication management for miscarriage.. Among those who did receive medication, the most effective approach was used less often.
The Supreme Court’s 2022 decision in Dobbs v.. Jackson Women’s Health Organization ended constitutional protection for abortion, and it triggered abortion bans in 14 states.. The study focused on first-trimester miscarriages treated before and after the Dobbs decision, using data from a commercial insurance database.. The dataset included almost 124,000 individuals aged 15 to 45 who had first trimester miscarriages.
Researchers compared miscarriage treatment patterns in states with bans—Alabama. Arkansas. Georgia. Idaho. Kentucky. Louisiana. Mississippi. Missouri. North Dakota. Oklahoma. South Dakota. Tennessee. Texas. and West Virginia—with comparison states without abortion bans.. The analysis period before Dobbs ran from January 2018 to May 2022, and the post-decision period ran from July 2022 to September 2024.. In the 14 ban states. there were about 54. 000 individuals with miscarriages; the rest were in the comparison states: Alaska. California. Colorado. Connecticut. Delaware. Illinois. Maine. Maryland. Michigan. Minnesota. Montana. New Jersey. New Mexico. New York. Oregon. Rhode Island. and Washington.
For people considering medication management, the study emphasized a key protocol: using both mifepristone and misoprostol.. Mifepristone blocks progesterone, a hormone that helps a pregnancy develop.. Misoprostol induces contractions.. According to the study’s framing. using both drugs results in complete expulsion of pregnancy tissue more often than misoprostol alone.
That matters because the research found a shift in practice patterns after Dobbs.. States with abortion bans were associated with a 2.2 percentage point drop in medication management for miscarriage compared with states without bans. alongside a 2.8 percentage point rise in expectant management.. The study also reported a 13.8 percentage point increase in misoprostol-only protocols for people in states with bans who did receive medication. rather than using both medications.
Rodriguez. an obstetrician and gynecologist at Oregon Health & Science University School of Medicine in Portland and a study coauthor. said there was not an across-the-board increase in expectant management requests.. “It’s confined to those states where there is an abortion ban.” She added that a person wanting medication management in states with abortion bans may not be getting that option. calling it “That’s putting a person in a tough place.”
Courtney Schreiber. an obstetrician and gynecologist at the University of Pennsylvania’s Perelman School of Medicine who was not involved in the research. described the situation as a system stress point rather than a simple clinical choice.. “Miscarriage is the most common complication of pregnancy. and the finding from this analysis demonstrate how vulnerable the patients are to breaks in the system. ” Schreiber said.. She also argued that people experiencing pregnancy loss are harmed by restrictions aimed at abortion care.. People suffering pregnancy loss are “experiencing additional psychological and physical harm as a result of policies that restrict access to abortion care. even though those restrictions should not apply to this population.”
The push and pull over miscarriage treatment is often immediate and deeply personal.. Rodriguez said bleeding. cramping. or pain in early pregnancy could indicate a miscarriage. “and you want to reach out to your clinician right away.” If a person is otherwise in good health. she said there is a choice in how to proceed: some prefer expectant management. while others want medication or a surgical procedure “to finish the expulsion of tissue as quickly as possible.” “We go by what patients prefer.”
The study’s drug access backdrop is more complex.. In January 2023, the U.S.. Food and Drug Administration removed the in-person dispensing requirement for mifepristone and allowed the medication to be mailed and made available at pharmacies.. But the agency kept other restrictions that can make acquiring and providing the drug challenging. even though mifepristone is safe and effective.. Clinicians providing obstetric and gynecological care in states with abortion restrictions are less likely to offer mifepristone as part of miscarriage treatment. research has found.
Daniel Grossman. obstetrician and gynecologist and director of Advancing New Standards in Reproductive Health at the University of California. San Francisco. who was not involved in the new research. said the findings document differences in clinical practice.. “Taken together with anecdotal reports of patients facing barriers to evidence-based miscarriage care in states with abortion bans. this study highlights how these laws are having broad impact on pregnant people.”
The pattern the study points to is tightly linked to timing and practice shifts: after Dobbs. states with bans showed a rise in expectant management and a drop in medication management. and when medication was used it more often took the misoprostol-only form rather than the mifepristone-plus-misoprostol protocol.
Rodriguez also criticized treating pregnancy care as separate pieces.. “The fact is. Rodriguez says. ‘you can’t just silo one aspect of pregnancy care’ as all of that care is inextricably linked.” She argued that women’s health is being shaped by political rules that do not reflect clinical expertise.. “Women’s health. in particular. is over-legislated. ” Rodriguez said. adding that laws “written by people who are not physicians. midwives. nurses. or have any medical expertise” amount to “essentially practicing medicine without a license. and when that happens. that’s going to harm people.”
At the heart of the medical stakes. the study cited that around 15 to 20 percent of known pregnancies end in miscarriage. often due to genetic abnormalities or without an apparent cause.. Early pregnancy loss affects approximately 1 million women in the United States each year. and miscarriage can put a person at risk of complications including infection and mental health conditions such as depression and posttraumatic stress disorder.
MISRYOUM’s newsroom notes the study’s bottom line is about real-world care choices after Dobbs—how quickly patients can access medication management, and whether the most effective regimen is available when needed.
Dobbs abortion bans miscarriage care mifepristone misoprostol JAMA expectant management first-trimester miscarriage reproductive health